# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-25-021723
Filing Date
2025-11-12
Accepted
2025-11-12 07:35:53
Documents
82
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | form10-q.htm iXBRL | 10-Q | 1281186
2 | EX-31.1 | ex31-1.htm | EX-31.1 | 15049
3 | EX-31.2 | ex31-2.htm | EX-31.2 | 14989
4 | EX-32 | ex32.htm | EX-32 | 10989
| Complete submission text file | 0001493152-25-021723.txt |  | 7334982

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | abeo-20250930.xsd | EX-101.SCH | 48749
6 | XBRL CALCULATION FILE | abeo-20250930_cal.xml | EX-101.CAL | 72473
7 | XBRL DEFINITION FILE | abeo-20250930_def.xml | EX-101.DEF | 212760
8 | XBRL LABEL FILE | abeo-20250930_lab.xml | EX-101.LAB | 471600
9 | XBRL PRESENTATION FILE | abeo-20250930_pre.xml | EX-101.PRE | 384675
84 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 1212226

Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 251468877
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)